Xtant Medical Holdings, Inc., a global company operating in surgical solutions for spinal, orthopedic, and wound care, has announced the commercial release of its CollagenX™. This product is a combination of bovine collagen particles and is designed to help close surgical wounds, which promotes healing and reduces the risk of wound reopening, as well as prevents infections. https://www.coherentmarketinsights.com/news/xtant-medical-launched-collagenxtm-for-commercial-use-1820